Health
Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight® Mental Health Monitor, a nationwide survey from Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, reveals that Americans feel mental health treatment isn’t designed with them in mind. The survey found that 41% of those diagnosed with depression and/or anxiety and who are currently taking a mental health medication think it feels “one-size-fits-all" and 74% of those who a
About this update from Myriad Genetics, Inc.
[{"type":"image","alt":"Myriad Genetics, Inc.","displaySize":"","headline":null,"caption":"Myriad Genetics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":138,"url":"https://media.zenfs.com/en/globenewswire.com/d43f1e89209f6724a2684841f43efbbf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6x2Laz667D2_wZOpyKoOpw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE5Mw--/https://media.zenfs.com/en/globenewswire.com/d43f1e89209f6724a2684841f43efbbf","width":300,"height":138}},"lazy":false},{"type":"text","content":"SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight® Mental Health Monitor, a nationwide survey from Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, reveals that Americans feel mental health treatment isn’t designed with them in mind.","length":330,"tagName":"p"},{"type":"text","content":"The survey found that 41% of those diagnosed with depression and/or anxiety and who are currently taking a mental health medication think it feels “one-size-fits-all" and 74% of those who are still finding a medication that works for them say that mental health treatment feels "one-size-fits-all.”","length":308,"tagName":"p"},{"type":"text","content":"Of those diagnosed with depression and/or anxiety, nearly two-thirds (67%) say their mental health is a daily struggle, and more than half (52%) feel the healthcare system treats them like part of an “assembly line” more than an individual.","length":240,"tagName":"p"},{"type":"text","content":""People are used to personalization in all aspects of their lives. It’s time we put the ‘me’ back in mental health care,” said Dr. Crystal Nelson, a board-certified psychiatrist and CEO of Blueprint Psychiatry in Atlanta. “The GeneSight Test can offer personalized genetic insights to help inform care, so patients can feel more confident in their treatment journey.”","length":372,"tagName":"p"},{"type":"text","content":"In a world where everything from entertainment to shopping recommendations are customized, some patients say mental health treatment is falling behind. Roughly 70% of those diagnosed with depression and/or anxiety think various aspects of their mental healthcare are only somewhat, not very, or not at all personalized to them while 88% indicate that they would be more ...